Trade fears recede as US profits jump

Investors have become a bit more upbeat on the trade outlook, and are looking forward to a “monster” US earnings season.


Xi and Trump: ready for a deal?
(Image credit: 2017 Getty Images)

Only last year it felt as though "volatility was AWOL and stocks moved steadily higher on a path that could be traced by a ruler", as Randall Forsyth puts it in Barron's. These days America's Dow Jones index swings by hundreds of points on a daily, or even hourly, basis. Global markets had a positive start to the week as there was no immediate reprisal to the strike on Syria, while receding fears over trade have also buoyed sentiment.

The worry is that the US and China could fulfil their threats to impose 25% tariffs on $150bn of each other's exports. But Donald Trump's sabre-rattlingmay merely be a bargaining strategy, Keith Wade of Schroders told The Times. Trump "has been wary of putting tariffs on goods which the US consumer would notice, such as iPhones". He expects China and the US to reach a deal on trade that could be "held up as a victory" ahead of the US midterm elections in November.

The world can shrug off this trade spat

Trump last week again said he wanted to negotiate with China. This also suggests that a deal is the most likely outcome, according to Capital Economics. But even if the tariffs go ahead, there will be little direct impact on the world economy: $150bn worth of exports comprise just 0.8% and 1.2% of GDP in the US and China respectively. Other big economies are "generally not that exposed to US-China trade through global supply chains". There would, of course, be a short-term effect on market and business confidence, which would undermine global growth.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

While investors have become a bit more upbeat on the trade outlook in the past few days, they are also looking forward to a "monster" US earnings season, says John Authers in the Financial Times. Usually, firms talk down their expectations as the earnings season approaches, ensuring that their shares bounce when they exceed their lowered expectations. This time they've dispensed with this charade and become increasingly bullish.

Can profits keep climbing?

This is due to the corporate tax cut agreed late last year, which analysts reckon will add 7% to year-on-year earnings-per-share growth in the first quarter of 2018. Profits are expected to have risen by over a fifth overall. This prospect explains why stocks have not fallen through their February lows. In the last 25 years, "share prices and earnings per share have tracked each other almost perfectly", says Authers; in the past five years 80% of the S&P 500's gains have come during earnings season. Still, given the forecasts, stocks bear "an unduly heavy burden of expectation". With valuations so high, there is little room for error, while historically high margins look set to come under pressure as the labour market tightens in the months ahead. So while earnings may boost stocks for now, in the longer term the momentum they provide is likely to ebb.

Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.